Rbcg | List of Frontiers open access articles

Original Research

Published on 06 Dec 2018

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity

in Vaccines and Molecular Therapeutics

Jorge A. Soto
Nicolás M. S. Gálvez
Claudia A. Rivera
Christian E. Palavecino
Pablo F. Céspedes
Emma Rey-Jurado
Susan M. Bueno
Alexis M. Kalergis

Frontiers in Immunology

doi 10.3389/fimmu.2018.02875

8,264 views
45 citations

Original Research

Published on 27 Mar 2018

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine

in Vaccines and Molecular Therapeutics

Byoung-Jun Kim
Bo-Ram Kim
Yoon-Hoh Kook
Bum-Joon Kim

Frontiers in Immunology

doi 10.3389/fimmu.2018.00643

9,347 views
20 citations

Mini Review

Published on 21 Oct 2021

The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview

in Infectious Agents and Disease

Esma Mouhoub
Pilar Domenech
Momar Ndao
Michael B. Reed

Frontiers in Microbiology

doi 10.3389/fmicb.2021.757858

5,821 views
19 citations

Original Research

Published on 28 Jan 2016

Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection

in Clinical and Diagnostic Microbiology and Immunology

Zheng Zhong Xu
Xiang Chen
Ting Hu
Chuang Meng
Xiao Bo Wang
Yan Rao
Xiao Ming Zhang
Yue Lan Yin
Zhi Ming Pan
Xin An Jiao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2016.00003

8,178 views
11 citations

Review

Published on 07 Apr 2014

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory

in Microbial Immunology

Adeliane C da Costa
Sarah Veloso Nogueira
André Kipnis
Ana Paula Junqueira-Kipnis

Frontiers in Immunology

doi 10.3389/fimmu.2014.00152

20,367 views
68 citations

Original Research

Published on 23 Jun 2020

Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity

in Microbial Immunology

Shiu-Ju Yang
Yih-Yuan Chen
Chih-Hao Hsu
Chia-Wei Hsu
Chun-Yu Chang
Jia-Ru Chang
Horng-Yunn Dou

Frontiers in Immunology

doi 10.3389/fimmu.2020.01298

6,583 views
19 citations

Articles

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine

The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview

Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory

Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity